Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

78.09
-0.9400-1.19%
Post-market: 78.090.00000.00%19:30 EDT
Volume:710.97K
Turnover:55.55M
Market Cap:3.43B
PE:-72.14
High:79.10
Open:78.67
Low:77.33
Close:79.03
52wk High:91.53
52wk Low:53.85
Shares:43.88M
Float Shares:35.64M
Volume Ratio:1.21
T/O Rate:1.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.88
PE(LYR):-49.11

Loading ...

Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Major Issues Report

Form 8-K - Current report
Jul 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]